TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Paul Martingell
VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm

Virbac has acquired a specialized liquid medication for feline hyperthyroidism from Norbrook for around £100 million. The product, currently generating €14 million in revenue, will be distributed under the Thyronorm and Felanorm brands across multiple markets.

Insights
MSpP   neutral

Standard financial transaction of acquiring minority stake without indicating positive or negative strategic implications


VBACY   positive

Expanding product portfolio, acquiring innovative treatment, potential for market growth and improved animal healthcare